- Previous Close
76.80 - Open
77.00 - Bid 77.50 x --
- Ask 80.65 x --
- Day's Range
72.25 - 84.00 - 52 Week Range
64.03 - 98.90 - Volume
822 - Avg. Volume
1,887 - Market Cap (intraday)
313.209M - Beta (5Y Monthly) -0.73
- PE Ratio (TTM)
90.24 - EPS (TTM)
0.89 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 16, 2021
- 1y Target Est
--
Choksi Asia Limited primarily engages in the manufacture and sale of photosensitized materials and other products for the healthcare industry in India. It offers portable ultrasound systems under K-magic and eSaote brand names for obstetrics/gynecology, abdominal, cardiovascular, and general-purpose applications, as well as its accessories, such as transesophageal, pencil doppler, convex, volumetric convex, micro- convex, liner, endocavity, and phased array probes. The company also provides X-ray films and chemicals, which include laser green, laser blue, and laser chemical products; X-ray accessories, comprising screens, cassettes, illuminators, and aprons; and laser NDT chemicals for processing industrial X-ray film. In addition, it trades in specialty x-ray films and medical equipment. The company was formerly known as Choksi Imaging Limited and changed its name to Choksi Asia Limited in April 2025. Choksi Asia Limited was incorporated in 1992 and is based in Mumbai, India.
www.choksiworld.comRecent News: CHOKSI.BO
View MorePerformance Overview: CHOKSI.BO
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHOKSI.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHOKSI.BO
View MoreValuation Measures
Market Cap
299.52M
Enterprise Value
277.19M
Trailing P/E
86.29
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.96
Price/Book (mrq)
1.90
Enterprise Value/Revenue
1.81
Enterprise Value/EBITDA
63.31
Financial Highlights
Profitability and Income Statement
Profit Margin
4.54%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
157.89M
Net Income Avi to Common (ttm)
7.17M
Diluted EPS (ttm)
0.89
Balance Sheet and Cash Flow
Total Cash (mrq)
12.63M
Total Debt/Equity (mrq)
14.31%
Levered Free Cash Flow (ttm)
--